Estia and Mayne Pharma to drop out of ASX 200.
SYDNEY: Aged care operator Estia Health and drugmaker Mayne Pharma will be among the major
SYDNEY: Aged care operator Estia Health and drugmaker Mayne Pharma will be among the major
FEATURED
Dementia care comes with ‘catastrophic’ costs for older adults
Clearday introduces digital assistants in residential care communities
Developers sit tight despite strong boomer demand
New village design redefining retirement with elevated living and bespoke care
Three students set to float healthcare startup for the elderly
First net zero retirement village opens for occupation
INNOVATION
